Promising results from a clinical trial of the LSD-like substance MM120 have persuaded the Food and Drug Administration (FDA) to award it “breakthrough therapy” status as a treatment for generalized anxiety disorder (GAD). The drugmaker behind MM120—Mind Medicine Inc., or MindMed—said in a press release Thursday that it plans... Read more

A GOP congressman is applauding the House passage of an appropriations package that includes report language urging the Justice Department and other agencies to study state regulatory frameworks for marijuana in anticipation of federal legalization. Rep. Dave Joyce (R-OH), co-chair of the Congressional Cannabis Caucus, said on Thursday that,... Read more

“As those great philosophers Tommy Chong and Cheech Marin would say, ‘It’s up in smoke.’” By Graham Moomaw, Virginia Mercury Hopes that Gov. Glenn Youngkin (R) might sign a bill legalizing retail sales of marijuana in Virginia faded fast this week as Democrats blocked one of the governor’s top... Read more

The National Animal Supplement Council (NASC) is promoting a new study that it says shows CBD is “safe for long-term use” in dogs—a significant finding given emerging research that cannabis can effectively treat conditions such as anxiety and certain skin diseases among canines. The study, published in the journal... Read more

Connecticut lawmakers took up a bill in committee on Wednesday that would decriminalize low-level possession of psilocybin, despite the governor’s office recently indicating that it has concerns about the psychedelics reform. The legislature’s Joint Judiciary Committee considered the proposal, which would make possession of up to one-half an ounce... Read more

Senate Majority Leader Chuck Schumer (D-NY) says that a bipartisan marijuana banking bill is among the policy priorities his chamber will “work very hard” to enact this year ahead of the upcoming elections. During a leadership press briefing on Wednesday, Schumer was asked what he thinks the Senate could... Read more